» Articles » PMID: 20354866

A Virulent Parent with Probiotic Progeny: Comparative Genomics of Escherichia Coli Strains CFT073, Nissle 1917 and ABU 83972

Overview
Specialty Genetics
Date 2010 Apr 1
PMID 20354866
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Escherichia coli is a highly versatile species encompassing a diverse spectrum of strains, i.e. from highly virulent isolates causing serious infectious diseases to commensals and probiotic strains. Although much is known about bacterial pathogenicity in E. coli, the understanding of which genetic determinants differentiates a virulent from an avirulent strain still remains limited. In this study we designed a new comparative genomic hybridization microarray based on 31 sequenced E. coli strains and used it to compare two E. coli strains used as prophylactic agents (i.e. Nissle 1917 and 83972) with the highly virulent uropathogen CFT073. Only relatively minor genetic variations were found between the isolates, suggesting that the three strains may have originated from the same virulent ancestral parent. Interestingly, Nissle 1917 (a gut commensal strain) was more similar to CFT073 with respect to genotype and phenotype than 83972 (an asymptomatic bacteriuria strain). The study indicates that genetic variations (e.g. mutations) and expression differences, rather than genomic content per se, contribute to the divergence in disease-causing ability between these strains. This has implications for the use of virulence factors in epidemiological research, and emphasizes the need for more comparative genomic studies of closely related strains to compare their virulence potential.

Citing Articles

Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Nissle 1917 strain.

Falzone L, Lavoro A, Candido S, Salmeri M, Zanghi A, Libra M Gut Microbes. 2024; 16(1):2397874.

PMID: 39229962 PMC: 11376418. DOI: 10.1080/19490976.2024.2397874.


Competitive fitness of asymptomatic bacteriuria strain 83972 against uropathogens in human urine.

George I, Kalairaj M, Zimmern P, Ware T, Subashchandrabose S Infect Immun. 2024; 92(6):e0017324.

PMID: 38780216 PMC: 11237815. DOI: 10.1128/iai.00173-24.


Utilizing genomic signatures to gain insights into the dynamics of SARS-CoV-2 through Machine and Deep Learning techniques.

Elsherbini A, Elkholy A, Fadel Y, Goussarov G, Elshal A, El-Hadidi M BMC Bioinformatics. 2024; 25(1):131.

PMID: 38539073 PMC: 10967124. DOI: 10.1186/s12859-024-05648-2.


Nissle 1917 Antagonizes Growth and Protects Intestinal Cells from -Mediated Damage.

Rebai Y, Wagner L, Gnaien M, Hammer M, Kapitan M, Niemiec M Microorganisms. 2023; 11(8).

PMID: 37630490 PMC: 10457924. DOI: 10.3390/microorganisms11081929.


High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917.

van t Hof M, Mohite O, Monk J, Weber T, Palsson B, Sommer M BMC Bioinformatics. 2022; 23(1):566.

PMID: 36585633 PMC: 9801561. DOI: 10.1186/s12859-022-05108-9.


References
1.
Chouikha I, Germon P, Bree A, Gilot P, Moulin-Schouleur M, Schouler C . A selC-associated genomic island of the extraintestinal avian pathogenic Escherichia coli strain BEN2908 is involved in carbohydrate uptake and virulence. J Bacteriol. 2006; 188(3):977-87. PMC: 1347334. DOI: 10.1128/JB.188.3.977-987.2006. View

2.
Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J . Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol. 2004; 186(16):5432-41. PMC: 490877. DOI: 10.1128/JB.186.16.5432-5441.2004. View

3.
Malchow H . Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?. J Clin Gastroenterol. 1998; 25(4):653-8. DOI: 10.1097/00004836-199712000-00021. View

4.
Schultz M . Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14(7):1012-8. DOI: 10.1002/ibd.20377. View

5.
Andersson P, Engberg I, Lincoln K, Hull R, Hull S, Svanborg C . Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun. 1991; 59(9):2915-21. PMC: 258113. DOI: 10.1128/iai.59.9.2915-2921.1991. View